Xtl Biopharmaceuticals Ltd (XTLB) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Xtl Biopharmaceuticals Ltd   (NASDAQ: XTLB)

Xtl Biopharmaceuticals Ltd Profitability Comparisons

Select each Category to receive further Information




XTLB Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q4 MRQ) - 70.29 % 63.43 % 52.58 %
Gross Margin (Q4 TTM) - 67.73 % 63.36 % 11.14 %
Gross Profit Margin 5 Yr. Avg. 0 % 62.06 % 62.12 % 45.39 %
EBITDA Margin (Q4 MRQ) - 18.08 % 16.57 % 13.41 %
EBITDA Margin (Q4 TTM) - 16.38 % 14.37 % 17.23 %
EBITDA Margin 5 Yr. Avg. --12332.22 % 27.97 % 22.95 % 19.9 %
Operating Margin (Q4 MRQ) - 10.9 % 10.98 % 21.64 %
Operating Margin (Q4 TTM) - 12.53 % 11.55 % -13.31 %
Operating Margin 5 Yr. Avg. --7618.52 % 16.07 % 14.81 % 15.8 %
Pre-Tax Profit Margin (Q4 MRQ) - 9.59 % 7.91 % 10.74 %
Pre-Tax Profit Margin (Q4 TTM) - 8.54 % 6.54 % 11.25 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.74 % 11.27 % 11.1 %
Net Margin (Q4 MRQ) - 12.34 % 9.5 % 9.01 %
Net Margin (Q4 TTM) - 11.66 % 7.82 % 9.36 %
Net Margin 5 Yr. Avg. - 8.17 % 7.66 % 8.9 %